Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1 alpha
- Authors
- Rho, Jin Kyung; Choi, Yun Jung; Lee, Jin Kyung; Ryoo, Baek-Yeol; Il Na, Im; Yang, Sung Hyun; Kim, Cheol Hyeon; Do Yoo, Young; Lee, Jae Cheol
- Issue Date
- Mar-2009
- Publisher
- SPANDIDOS PUBL LTD
- Keywords
- gefitinib; epidermal growth factor receptor; hypoxia; hypoxia-inducible factor-1 alpha; lung cancer; resistance
- Citation
- ONCOLOGY REPORTS, v.21, no.3, pp.801 - 807
- Indexed
- SCIE
SCOPUS
- Journal Title
- ONCOLOGY REPORTS
- Volume
- 21
- Number
- 3
- Start Page
- 801
- End Page
- 807
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/120458
- DOI
- 10.3892/or_00000287
- ISSN
- 1021-335X
- Abstract
- Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a transcriptional factor which is activated by hypoxia and associated with cell survival, proliferation and drug resistance. Recent studies have shown that the down-stream molecules of the epidermal growth factor receptor (EGFR) signal are involved in the hypoxia-dependent or -independent HIF-1 alpha protein accumulation. Thus, we hypothesized that an EGFR-TK inhibitor, gefitinib, might circumvent the hypoxia-induced drug resistance via the regulation of HIF-1 alpha expression. In our data, treatment of gefitinib suppressed induced HIF-alpha by hypoxia. This action of gefitinib was caused by reduced protein stability without any change in the level of HIF-1 alpha mRNA. The effect of gefitinib on down-regulation of HIF-1 alpha was reversed by transfection of constitutively active form of Akt. The cellular response to gefitinib was similar in both normoxia and hypoxia condition. However, the response to conventional chemotherapeutic drugs decreased > 50% under hypoxia condition and they did not change HIF-1 alpha expression. In addition, the suppression of HIF-1 alpha using siRNA overcame partially hypoxia-induced drug resistance. In conclusion, gefitinib was able to circumvent hypoxia-induced drug resistance suggesting that the effective suppression of HIF-1 alpha by the inhibition of EGFR-Akt pathway may overcome the hypoxia-induced drug resistance.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.